The When, Why, and How of Using Glycopyrronium to Diminish Drooling in Children with Neurodevelopmental Disabilities: Implications for Clinical Practice

Despite the established efficacy of glycopyrronium bromide in reducing drooling among children with neurodevelopmental disabilities, evidence on its impact on the daily lives of children and parents and effectiveness in a real-world setting are scarce, especially among long-term users. This study explored timing and duration of glycopyrronium treatment, effect and impact on daily life, and occurrence of side effects to inform clinical practice.